Evidence map›Paper›PMID 39242971›Full record

ReviewEMBO molecular medicine2024

The influence of AHR on immune and tissue biology.

Brigitta Stockinger, Oscar E Diaz, Emma Wincent

Abstract readReview
In one paragraph

Review in EMBO molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Aryl hydrocarbon receptor activation alters emergency hematopoiesis during influenza A virus infection.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. The AhR pathway is dysregulated in alopecia areata.Journal of translational autoimmunity · 2025
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brigitta StockingerThe Francis Crick Institute, London, United Kingdom. brigitta.stockinger@crick.ac.uk.ORCID 0000-0001-8781-336X
Oscar E DiazThe Francis Crick Institute, London, United Kingdom.ORCID 0000-0001-7622-7832
Emma WincentInstitute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0003-1637-654X

Funding

Svenska Forskningsrådet Formas (Formas) FR-2021/0005Swedish Research Council VR 2020-03418Wellcome Trust CC2016Wellcome Trust (WT) 210556/Z/18/Z
6 · The paper itself

Abstract

The aryl hydrocarbon receptor is a ligand dependent transcription factor which functions as an environmental sensor. Originally discovered as the sensor for man made pollutants such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) it has recently gained prominence as an important mediator for environmental triggers via the diet or microbiota which influences many physiological functions in different cell types and tissues across the body. Notably AHR activity contributes to prevent excessive inflammation following tissue damage in barrier organs such as skin, lung or gut which has received wide attention in the past decade. In this review we will focus on emerging common AHR functions across cell types and tissues and discuss ongoing issues that confound the understanding of AHR physiology. Furthermore, we will discuss the need for deeper molecular understanding of the functional activity of AHR in different contexts with respect to development of potential therapeutic applications.

Indexed as

Receptors, Aryl HydrocarbonAnimalsHumansReceptors, Aryl HydrocarbonAryl Hydrocarbon ReceptorBarrier OrgansCytochrome P4501Intestinal EpitheliumTissue Repair

Identifiers

PMID39242971
PMCPMC11473696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.